ERTUVIA Tablets 5Mg (1 Box = 14 Tablets)

Specification Requires Prescription (YES/NO) Yes Generics Ertugliflozin Used For Diabetes How it works Ertugliflozin : Ertugliflozin is...
SKU: ERTUVIA Tablets 5Mg (1 Box = 14 Tablets)
Availability: Many In Stock
Product Type: Consumer
Rs.324.00
Rs.360.00
Rs.324.00
Please hurry! Only 0 left in stock
Subtotal: Rs.324.00
10 customers are viewing this product

Standard Shipping

standard shipping charges on order is Rs 200

Returns Policy

3 days refund after delivery policy Learn More.

Delivery Within 5 - 7 Bussiness Days

ERTUVIA Tablets 5Mg  (1 Box = 14 Tablets)

ERTUVIA Tablets 5Mg (1 Box = 14 Tablets)

Rs.360.00 Rs.324.00

ERTUVIA Tablets 5Mg (1 Box = 14 Tablets)

Rs.360.00 Rs.324.00

Specification

Requires Prescription (YES/NO)

Yes

Generics

Ertugliflozin

Used For

Diabetes

How it works

Ertugliflozin : Ertugliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, Ertugliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose, and thereby increases urinary glucose excretion. Ertugliflozin also causes an osmotic diuresis, which may result in increase of urinary glucose excretion. 

Usage And Safety

Dosage

Ertugliflozin

Side Effects

Pancreatitis, hypotension, ketoacidosis, acute kidney injury, impairment in renal function, urosepsis, pyelonephritis, lower limb amputation, heart failure, hypoglycemia with concomitant use with insulin and insulin secretagogues, necrotizing fasciitis of the perineum (fournier’s gangrene), genital mycotic infections, hypersensitivity reactions, increases in low-density lipoprotein, severe and disabling arthralgia, bullous pemphigoid, upper respiratory tract infection, nasopharyngitis, urinary tract infections, vaginal pruritus, increased urination, back pain, weight decreased and headache.

Drug Interactions

It may increase the risk of hypoglycemia when used in combination with insulin and/or an insulin secretagogue.Patients receiving digoxin should be monitored appropriately .

Indication

It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both Ertugliflozin and Sitagliptin is appropriate.

When not to Use

Known hypersensitivity to Ertugliflozin, Sitagliptin and to any of the excipient of the product. - Severe renal impairment, end-stage renal disease (ESRD) or on dialysis.

Precautions

Precaution

Patients should be observed carefully for signs and symptoms of pancreatitis.

Warnings

Warning 1

Ertugliflozin causes intravascular volume contraction.

Warning 2

Treatment with medicines containing SGLT2 inhibitors increases the risk for urinary tract infections. Evaluate patients for signs and symptoms of urinary tract infections and treat promptly, if indicated.

Additional Information

Pregnancy category

Always consult your physician before using any medicine.

Storage (YES/NO)

Store this medicine at room temperature, away from direct light and heat.

Related Products

Recently Viewed Products